Bacterin announced that clinical outcomes of the use of its OsteoSponge bone graft for foot and ankle fusion procedures have been published in the March issue of Orthopedics.
The journal article reports a prospective analysis of 25 patients who underwent foot and ankle arthrodesis involving 45 total joints.
According to the study, 96 percent of patients showed radiographic fusion at 6 and 12 months after the procedure, with a 97.4 percent overall fusion rate. Pain was assessed pre and postoperatively and statistically significant improvements were recorded at 6 and 12 months after surgery, as compared to preoperative pain scores.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws